Pfizer Inc. (PFE)
27.60
-0.04
(-0.16%)
USD |
NYSE |
Sep 11, 13:46
Pfizer Gross Profit (TTM) : 41.30B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.30B |
| March 31, 2026 | 41.25B |
| December 31, 2025 | 41.45B |
| September 30, 2025 | 43.40B |
| June 30, 2025 | 42.99B |
| March 31, 2025 | 41.81B |
| December 31, 2024 | 42.48B |
| September 30, 2024 | 35.49B |
| June 30, 2024 | 27.61B |
| March 31, 2024 | 27.78B |
| December 31, 2023 | 29.82B |
| September 30, 2023 | 37.23B |
| June 30, 2023 | 49.99B |
| March 31, 2023 | 60.25B |
| December 31, 2022 | 62.58B |
| September 30, 2022 | 62.35B |
| June 30, 2022 | 59.88B |
| March 31, 2022 | 52.26B |
| December 31, 2021 | 46.91B |
| September 30, 2021 | 41.70B |
| June 30, 2021 | 35.94B |
| March 31, 2021 | 32.06B |
| December 31, 2020 | 29.85B |
| September 30, 2020 | 30.98B |
| June 30, 2020 | 32.45B |
| Date | Value |
|---|---|
| March 31, 2020 | 34.79B |
| December 31, 2019 | 37.01B |
| September 30, 2019 | 37.62B |
| June 30, 2019 | 38.10B |
| March 31, 2019 | 37.96B |
| December 31, 2018 | 37.61B |
| September 30, 2018 | 37.25B |
| June 30, 2018 | 37.09B |
| March 31, 2018 | 36.77B |
| December 31, 2017 | 36.74B |
| September 30, 2017 | 36.87B |
| June 30, 2017 | 36.75B |
| March 31, 2017 | 36.78B |
| December 31, 2016 | 36.87B |
| September 30, 2016 | 37.17B |
| June 30, 2016 | 37.06B |
| March 31, 2016 | 36.82B |
| December 31, 2015 | 35.70B |
| September 30, 2015 | 35.47B |
| June 30, 2015 | 35.59B |
| March 31, 2015 | 36.14B |
| December 31, 2014 | 36.30B |
| September 30, 2014 | 36.48B |
| June 30, 2014 | 36.68B |
| March 31, 2014 | 36.93B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Johnson & Johnson | 66.63B |
| Eli Lilly & Co. | 66.44B |
| Merck & Co., Inc. | 48.01B |
| Bristol Myers Squibb Co. | 32.78B |
| Viatris, Inc. | 5.838B |